These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 9353393)
1. Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1. Dooley CT; Spaeth CG; Berzetei-Gurske IP; Craymer K; Adapa ID; Brandt SR; Houghten RA; Toll L J Pharmacol Exp Ther; 1997 Nov; 283(2):735-41. PubMed ID: 9353393 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2. Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells. Wright KE; McDonald J; Barnes TA; Rowbotham DJ; Guerrini R; Calo' G; Lambert DG Neurosci Lett; 2003 Aug; 346(3):145-8. PubMed ID: 12853105 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies on high affinity NOP-active hexapeptides. Judd AK; Tuttle DJ; Jones RW; Sanchez A; Polgar W; Berzetei-Gurske I; Toll L J Pept Res; 2004 Sep; 64(3):87-94. PubMed ID: 15317498 [TBL] [Abstract][Full Text] [Related]
5. In vitro binding and functional studies of Ac-RYYRIK-ol and its derivatives, novel partial agonists of the nociceptin/orphanin F/Q receptor. Gunduz O; Sipos F; Spagnolo B; Kocsis L; Magyar A; Orosz G; Borsodi A; Calò G; Benyhe S Neurosignals; 2006-2007; 15(2):91-101. PubMed ID: 16874009 [TBL] [Abstract][Full Text] [Related]
6. Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells: functional homology with opioid receptors. Fawzi AB; Zhang H; Weig B; Hawes B; Graziano MP Eur J Pharmacol; 1997 Oct; 336(2-3):233-42. PubMed ID: 9384238 [TBL] [Abstract][Full Text] [Related]
7. N-terminal modifications leading to peptide ORL1 partial agonists and antagonists. Judd AK; Kaushanskaya A; Tuttle DJ; Sanchez A; Khroyan T; Polgar W; Toll L J Pept Res; 2003 Nov; 62(5):191-8. PubMed ID: 14531842 [TBL] [Abstract][Full Text] [Related]
8. Effects of [(pF)Phe(4)]nociceptin/orphanin FQ-(1-13)NH(2) on GTPgamma(35)S binding and cAMP formation in Chinese hamster ovary cells expressing the human nociceptin/orphanin FQ receptor. McDonald J; Barnes TA; Calo G; Guerrini R; Rowbotham DJ; Lambert DG Eur J Pharmacol; 2002 May; 443(1-3):7-12. PubMed ID: 12044785 [TBL] [Abstract][Full Text] [Related]
9. Binding and GTPgammaS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors. Neal CR; Owens CE; Taylor LP; Hoversten MT; Akil H; Watson SJ J Chem Neuroanat; 2003 Jul; 25(4):233-47. PubMed ID: 12842269 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies. Spagnolo B; Carrà G; Fantin M; Fischetti C; Hebbes C; McDonald J; Barnes TA; Rizzi A; Trapella C; Fanton G; Morari M; Lambert DG; Regoli D; Calò G J Pharmacol Exp Ther; 2007 Jun; 321(3):961-7. PubMed ID: 17329552 [TBL] [Abstract][Full Text] [Related]
12. Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors. Hashimoto Y; Calo' G; Guerrini R; Smith G; Lambert DG Eur J Pharmacol; 2002 Aug; 449(1-2):17-22. PubMed ID: 12163101 [TBL] [Abstract][Full Text] [Related]
13. Opioid receptor-like 1 (ORL1) receptor binding and the biological properties of Ac-Arg-Tyr-Tyr-Arg-Ile-Arg-NH2 and its analogs. Ambo A; Kohara H; Kawano S; Sasaki Y J Pept Sci; 2007 Oct; 13(10):672-8. PubMed ID: 17712865 [TBL] [Abstract][Full Text] [Related]
14. Species differences in the efficacy of compounds at the nociceptin receptor (ORL1). Burnside JL; Rodriguez L; Toll L Peptides; 2000 Jul; 21(7):1147-54. PubMed ID: 10998550 [TBL] [Abstract][Full Text] [Related]